$14.65 -0.31 (-2.04%)
2/10/2012 4:00 PM

Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA)

CAPS Rating: 2 out of 5

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules.

Featured Broker Partners


Advertisement